Effects of cigarette smoke (CS) on eosinophils (EOS), important cells involved in the pathogenesis of chronic lung diseases such as asthma, were studied in vitro. EOS were isolated from healthy and mildly atopic donors and exposed to soluble components of cigarette smoke (CSE). Viability and apoptosis were assessed by flow cytometry after staining with propidium iodide and Annexin-V. Activation was determined by release of newly-synthesized (IL-8, IL-6) mediators and by phosphorylation of MAPKs. CSE effects on ultrastructural morphology and production of neutrophil chemotactic factors in CSE-activated EOS were also evaluated. CSE concentrations from 0-2.5% were non-toxic for up to 18-24 hours of exposure. However, CSE at 2.5% activated EOS as evidenced by ultrastructural degranulation: release of IL-8 and IL-6, and increased expression of the MAPK, c-Jun. Supernatants from CSE-activated EOS were found to be significantly chemotactic for neutrophils. These results suggest that CS may aggravate lung inflammation by activating EOS which, in turn, release inflammatory mediators promoting inflammatory cell recruitment and lung remodeling.
INTRODUCTION
Eosinophils (EOS) are terminally differentiated granular leukocytes that are produced in the bone marrow and migrate to inflamed tissues in response to chemotactic signals. Their recruitment, growth and survival are supported by cytokines and chemokines such as granulocytemacrophage colony stimulating factor (GM-CSF), and interleukins (IL)-3 and -5 [ 1 , 2 , 3 , 4 ]. Eosinophilia occurs in response to parasitic infection and exposure to allergens. Eosinophils are particularly evident in chronic lung inflammation where their products appear to play roles both in bronchial hyper-responsiveness and in tissue remodeling, leading to compromised lung function [ 5 , 6 ] . Increased numbers of eosinophils in the bronchial mucosa have been correlated with a number of conditions such as: bronchial wall thickening, epithelial cell hypertrophy, and myofibroblast hyperplasia [ 7 ] ; Goblet cell hyperplasia and increased mucus production [ 7 ] ; and tissue remodeling [ 8 ] ; and fibrosis [ 9 ] . Neutralization of IL-5, the main eosinophil growth factor, has been shown to block airway hyperreactivity [ 10 ] .
Many of the eosinophil mediators involved in the pathogenesis of airway inflammation are preformed and stored in granules that are released upon eosinophil activation. These include: major basic protein (MBP) whose levels are correlated with bronchial epithelial damage [ 11 ] ; eosinophil cationic protein (ECP) which has been shown to be elevated in chronic asthma and associated with airflow obstruction [ 12 ] ; eosinophil-derived neurotoxin (ECN) which stimulates fibroblast proliferation [ 13 ] ; and eosinophil peroxidase (EPO) which catalyzes the peroxidation of halides and forms toxic nitrogen reactive species that contribute to asthmatic inflammation [ 14 ] . EPO, which is used as a biomarker of eosinophil degranulation (i.e., activation) [ 15 ] , inactivates leukotrienes that cause bronchoconstriction [ 16 ] . MBP, the main granule constituent also induces degranulation of tissue mast cells, which contribute to airway hyper-responsiveness and inflammation [ 17 ] . Additionally, eosinophil cytoplasmic lipid bodies contain cyclooxygenases (COX), lipoxygenases, and phospholipase A2, all of which contribute to inflammation through their role in synthesis of proinflammatory eicosanoids [ 18 ] . Upon activation, eosinophils also synthesize and release a variety of proinflammatory cytokines including: the interleukins IL-1α, IL-6, IL-8; tumor necrosis factor-alpha (TNF-α); transforming growth factors (TGF)-α and β and eotaxin [ 19 , 20 ] . TNF-α, which is also produced by several other inflammatory cell types, causes recruitment of eosinophils and neutrophils to inflamed tissues, induces eosinophil synthesis and release of matrix metalloproteinases (MMPs) involved in lung tissue remodeling, and synergizes with GM-CSF to promoting eosinophil survival [ 21 ] . It induces eosinophil synthesis and release of IL-8, an important chemotactic and activating factor for neutrophils and lymphocytes [ 22 , 23 ] which induces adhesion molecule expression also triggers the oxidative burst response, contributing to tissue damage [ 24 ] . IL-6, a highly pleiotrophic cytokine, stimulates a variety of immune and inflammatory responses and plays an important role in airway inflammation [ 25 , 26 , 27 ]. Eosinophil-derived TGF-β promotes lung fibrosis by stimulating fibroblast proliferation and synthesis of extracellular matrix (ECM) components such as collagen [ 28 ] . Thus, intrinsic agents (such as TNF-α and C5a) and extrinsic agents which persistently activate airway eosinophils may induce an inflammatory cascade leading not only to chronic inflammation but also lung tissue remodeling and compromise of lung function.
The adverse effects of long term exposure to cigarette smoke (CS) on human health are increasingly being documented both in human and animal studies. CS exposure is associated with reduced immune function [ 29 , 30 ] . Exposure to CS also influences inflammatory responses by enhancing release of proinflammatory cytokines [ 31 , 32 ] . CS is composed of a multitude of potentially harmful chemicals including aldehydes (formaldehyde, acrolein), ketones, organic acids, phenols, cyanides, nitrogen oxides (NO) and reactive oxygen species (ROS); thus, exposure to CS likely induces a state of oxidative stress leading to release of proinflammatory cytokines such as TNF-α, IL-6 and IL-8 through activation of stress kinases such as JNK and p38 and redox-sensitive transcription factors such as NF-κB and AP-1 [ 33 ] . Other CS components such as formaldehyde and acrolein enhance neutrophil migration into the lung [ 34 ] and inhibit apoptosis of neutrophils [ 35 ] and high concentrations of nicotine stimulate neutrophil degranulation [ 36 ] . In both humans and animals, CS induces release of chemokines such as monocyte chemotactic protein (MCP)-1 and IL-8 that attract monocytes/macrophages and neutrophils to the lung [ 37 ] . In vitro exposure to CS directly activates human bronchial epithelial cells, lung fibroblasts, and alveolar macrophages resulting in release of inflammatory mediators such as IL-8 [ 32 , 38 , 39 , 40 ]. Levels of TNF-α and IL-6 are often found to be elevated in the lungs of smokers [ 41 ] . While these proinflammatory cytokines may have several cellular sources (in addition to eosinophils) observations in animal models and humans suggest that CS may influence survival, recruitment, and activation of eosinophils. Guinea pigs repeatedly exposed to CS demonstrated eosinophilic infiltration in the lung mucosa [ 42 ] . Observations of increased airway remodeling in asthmatic smokers in comparison to asthmatic non-smokers [ 43 ] , reduced peripheral blood eosinophil counts [ 44 ] and increased numbers of eosinophils in bronchial lavage fluids of (BALF) smokers [ 45 ] suggest that these inflammatory cells may also be affected by CS exposure. However, other than what has been described above little is known about the effects of CS on eosinophil survival and functional status. We undertook a preliminary investigation to examine the effects of CS exposure in vitro on eosinophil survival, response to activating agents such as TNF-α and C5a, and their elaboration of proinflammatory cytokines -in particular, IL-6 (which has been shown to be elevated in the lungs of smokers and animals exposed to CS [ 20 , 41 , 42 , 45 ], and IL-8, a major chemotactic factor for neutrophils which may be affected by exposure to CS [ 32 ] .
MATERIALS AND METHODS.
Production of cigarette smoke extract (CSE): Smoke from one cigarette (Marlboro Lights, Phillip Morris, estimated to contain 10 mg tar, 0.8 mg, 11 mg carbon monoxide at the smoker end [ 46 ] ) was extracted under vacuum for 5 min into 10 ml of culture medium using an apparatus designed for this purpose as previously described [ 47 ] . The solution was subsequently sterilized through a 0.45 m disposable filter. The cigarette smoke extract (CSE) was prepared freshly for each experiment and assigned an absolute value of 100% Purification of eosinophils from peripheral human blood: Heparinized blood (150 ml) was collected by venipuncture from non atopic and atopic volunteers. Informed consent was obtained from all volunteers according to the guidelines established by the Hadassah-Hebrew University Human Experimentation Helsinki Committee. Samples were treated and tested separately. The blood was mixed with dextran (50 ml blood: 10 ml dextran) and erythrocytes were allowed to sediment for 45 min at 37°C. The buffy coat was collected, layered over Ficoll-Hypaque (Histopaque® -1077, 1.77g/ml, Sigma-Aldrich, St. Louis, MO); granulocytes were separated by density gradient centrifugation performed at room temperature. The pellet was collected and residual erythrocytes were removed by hypotonic lysis, leaving a population consisting of neutrophils and eosinophils. Eosinophils were separated from neutrophils by negative immunomagnetic selection with a magnetic cell separation were washed in Annexin V buffer and then incubated for 20 min with Annexin V-FITC according to a standard protocol established in our laboratory [ 72 ] . Cells washed again and PI was added and subsequently analyzed by flow cytometry (FACScalibur, Becton Dickenson, San Jose, CA).
Electron microscopy: Eosinophils were fixed in Karnovsky's fixative solution and processed as previously described [ 48 ] . Sections were observed with a Joel 100CX transmission electron microscope (TEM) and with a Philips CM12 TEM equipped with a goniometer. Eosinophils were photographed at random. These studies were performed in the laboratory of Professor Ilan Hammel (Department of Pathology, Tel Aviv University, Tel Aviv, Israel).
Measurement of IL-8 and IL-6 supernatants from cultured eosinophils: Concentrations of IL-8 and IL-6 in culture supernatants were measured using commercial ELISA kits (IL-8 DuoSet ELISA development kit, IL-6 DuoSet ELISA development kit, both from R&D Systems, Minneapolis, MN, USA) and according to the manufacturer's instructions.
Neutrophil transmigration assay: Neutrophil transmigration was measured using a microwell dual chamber system (Chemotex Microwell dual chamber system, filter pore size 5 µm, 6·0 mm diameter wells, from NeuroProbe Inc., Gaithersburg, MD). Samples from individual donors were treated separately for both eosinophil and neutrophil populations. Supernatants of eosinophils cultured for 18h in medium alone, or in medium containing 2.5% of CSE, were first added in triplicates to wells in the bottom chamber and covered with a framed filter. Next, neutrophils [30,000 cells in 30µl of culture medium] were placed on the top of the filter over each well and the chamber system was incubated for 90 min [37°C, 5% CO 2 ] to allow neutrophils to migrate through the filter in response to chemotactic factors present in the well. After incubation, the remaining neutrophil suspensions on the top of the filter were removed using tissue paper and plate was centrifuged [for 1 min at 600 g] to collect cells attached on the bottom of the filter. Then, cells in the lower chamber were enumerataed by flow cytometry by acquiring events for 1 min according to a standard protocol established in our laboratory [ 71 ] Intracellular staining for flow cytometric analysis of protein expression: Eosinophils were activated (as described above) and exposed to 2.5% CSE, then immediately fixed [ 
RESULTS.
Effects of CSE on viability and induction of apoptosis in human eosinophils. The threshold of eosinophil sensitivity to CSE, optimal CSE working concentration and exposure time were established. As GM-CSF is the main survival factor of eosinophils the effect of CSE on GM-CSF-mediated eosinophil survival was also assessed. Viability and apoptosis were measured by AnnexinV/PI staining and flow cytometry and results are shown in Fig. 1 . At CSE concentrations between 2.5% and 5% a slight increase in the rate of apoptosis was observed (Fig. 1A) . After 24h of exposure to CSE, even in absence of GM CSF no change in number of apoptotic cells was measured at CSE concentrations of ≤2.5%. However, after 48h of culture, 62.25% of the unexposed cells stained for Annexin V. Nevertheless, in CSE-exposed cells the percentage of cells undergoing apoptosis was markedly higher at all CSE concentrations (2.5% CSE: 76%; 5% CSE: 77%; 10% CSE: 81%). At 48 hours, even in the presence of GM-CSF, a dramatic increase of apoptotic cells from 11% to 72% was observed. In the absence of GM-CSF, eosinophil survival was reduced over time in culture regardless; however, exposure to CSE for 24-48h contributed significantly to the decline in eosinophil viability at all CSE concentrations tested (Fig.  1B) . In the presence of GM-CSF, eosinophil viability was not markedly affected by exposure to CSE concentrations of ≤2.5% for 24-48h. However, this was not the case at [CSE] > 2.5%. Thus, at lower CSE concentrations (i.e., 2.5% and lower) the addition of the survival factor, GM-CSF appeared to partially rescue eosinophils from the additional toxic effects of CSE. It also appeared that the interval between 12-24h was a critical determinant of eosinophil survival in the absence of GM-CSF and after exposure to CSE.
Exposure to CSE at concentrations of 2.5% for 18 hours does not adversely affect the viability of eosinophils. Based on the results described above 2.5% CSE was chosen as the optimal concentration. At this concentration, eosinophil survival was neither adversely affected nor improved by addition of GM-CSF. However, at higher CSE concentrations, eosinophil survival was decreased even in the presence of GM-CSF. Thus, we determined the optimal exposure time for 2.5% CSE concentration and its affect on eosinophil activation with agents such as TNF-α. Eosinophils were incubated in the presence of 2.5% CSE for 18h. In these experiments untreated cells were compared to CSE (2.5%)-treated cells incubated in the presence or absence of TNF-α [5000 U] or GM-CSF [20 ng/ml]. Viability was determined by PI staining and flow cytometry and results are shown in Fig. 2 . Exposure to 2.5% CSE did not affect eosinophil viability after 18h and addition of GM-CSF or TNF-α did not influence the outcome with respect to eosinophil viability. Based on these results, in subsequent
In Vitro Exposure To Cigarette Smoke Activates Eosinophils: Implications For Lung Inflammation
experiments eosinophils were cultured for no longer than 18h and at CSE concentrations not exceeding 2.5%. Exposure to 2.5% CSE for 18h induces ultrastructural morphological changes in eosinophils. To determine whether CSE induces ultrastructural changes in eosinophils exposed to 2.5% CSE for 18h were fixed, sectioned, and examined by transmission electron microscopy and these were compared to cells incubated for the same period of time in medium without CSE. A representative electron micrograph of untreated eosinophils cultured for 18h is shown in Fig. 3A .
In this cell some granules are electron-transparent suggesting partial degranulation ("piecemeal degranulation") while the majority of granules appear normal, containing core protein, visible as a large crystal structure within the granule. The CSE-exposed eosinophil shown in Fig. 3B appears enlarged in comparison to the untreated cell (Fig. 3A) and most of its granules are electron transparent, lacking the core crystal. Its cytoplasm contains numerous vesicles and an area of "cloudy swelling" suggestive of hydropic degeneration due to cellular stress. Electron micrographs of cells that were incubated with GM-CSF [10ng/ml] and TNF-α [5000U] are shown in Figs. 3C and 3D. In the eosinophil incubated with GM-CSF and TNF-α, but not exposed to CSE (Fig. 3C) , the granule content and the crystal core appear more electrondense than the untreated control eosinophil (Fig. 3A) suggesting that GM CSF and TNF-α support cell viability and stability despite the physiologic stress imposed by culture conditions. Its cytoplasm has a vesicular appearance suggesting "piecemeal degranulation" as a result of TNF α activation of the cell. While the eosinophil shown in Fig. 3D was also exposed to 2.5% CSE for 18h the majority of its granules contain their crystal core, suggesting that in the presence of GM CSF and TNF-α eosinophil structure is more preserved. However, in some granules the crystals appear partially dissolved and many vesicles are scattered within the cytoplasm suggesting that CSE is enhancing "piecemeal degranulation" in response to the culture conditions. Thus, while the culture conditions activate eosinophils to some degree, exposure to CSE appears to augment eosinophil activation as evidenced by loss of granule contents. Exposure to CSE in vitro increases release of IL-8 and IL-6 from eosinophils. IL-8 and in particular, IL-6 play an important role in CS-induced lung injury as well as in asthma and it is known that in vitro stimulation of eosinophils with GM-CSF and TNF-α can induce their synthesis [ 22 ] . TNF-α is one of the mediators that are increased in the lung microenvironment following CS-induced lung injury. As exposure of eosinophils to CSE differentially affected degranulation in activated eosinophils (described above), the possibility that it would also affect pro-inflammatory cytokine release by GM-CSF/TNF-α-activated eosinophils was also investigated. To exclude the possibility that CSE affects only the release and not the de novo synthesis of these cytokines, the protein synthesis inhibitor cycloheximide was included as a control in parallel cultures for all treatments. IL-8 and IL-6 concentrations in eosinophil culture supernatants were determined by ELISA. IL-8 concentrations (Fig. 4) in supernatants of eosinophils cultured in the presence of 2.5% CSE (without GM-CSF and TNF-α) were significantly higher in comparison to those in supernatants of cells not exposed to CSE (378 ± 18 pg/ml vs. 105 ± 25pg/ml p < 0.02). IL-8 release into culture supernatants of eosinophils activated with GM-CSF + TNF-α then exposed to 2.5% CSE was significantly higher in comparison with eosinophils activated in medium alone (975 ± 10 pg/ml vs. 362 ± 13 pg/ml p < 0.02). Concentrations of IL-6 ( Fig. 5) in supernatants of eosinophils cultured in the presence of 2.5% CSE were also significantly higher in comparison to those in supernatants of cells cultured in medium alone (400 ± 67 pg/ml vs. 1329 ± 302 pg/ml p < 0.05). In eosinophils activated with GM-CSF + TNF-α and exposed to 2.5% CSE, IL-6 release was significantly increased (770 ± 19 pg/ml vs. 2174 ± 610 pg/ml p < 0.05) in comparison with eosinophils activated in medium alone. This effect on IL-8 and IL-6 release was not observed in cyclohexamide-treated eosinophils, suggesting that CSE influences de novo synthesis of these cytokines. Supernatants from CSE-activated eosinophils enhance neutrophil chemotaxis. Neutrophils play a major role in lung inflammation induced by cigarette smoke exposure. Soon after exposure of lung to cigarette smoke an influx of neutrophils into the lung has been observed [ 37 ] and IL-8 is a major chemoattractant for neutrophils [ 49 ] . As exposure of eosinophils to 2.5% CSE induced synthesis and release of IL-8, the possibility that CSE might indirectly induce neutrophil chemotaxix by this mechanism was investigated using a dual chamber microwell system in which supernatants of CSE-activated eosinophils were used to attract neutrophils. Supernatants of eosinophils cultured in 2.5% CSE for 18h significantly increased neutrophil migration in comparison to supernatants from eosinophils cultured in medium, alone (Fig. 6) . Thus, CSE-activated eosinophils contained significant chemotactic activity for neutrophils. While IL-8 may have been responsible for this effect this was not confirmed in this study.

Figure 6
Figure 6: Supernatants from CSE-activated eosinophils enhance neutrophil chemotaxis. Neutrophils [10/ml] were incubated with supernatants of eosinophils that were incubated for 18h with or without 2.5% CSE. Neutrophil migration was evaluated as described in Materials and Methods. Results of experiments performed with two different donors are shown. Tests were performed in triplicate. Control: neutrophil migration in culture medium, alone.
In vitro exposure to CSE increases c-Jun protein levels in eosinophils. Mast cell derived tryptase induces IL-8 synthesis in human peripheral blood eosinophils [ 50 ] in a MAPK/AP-1-dependent pathway that leads to activation of c-Jun. To examine the possibility that in vitro exposure of CSE induces IL-8 release from eosinophils by a similar mechanism, eosinophils were activated for various times ranging from 0 to 360 min, and c-Jun protein levels were measured by flow cytometry after intracellular staining with specific antibodies. A transient increase in c-Jun protein expression was observed after 30 min in cells that were incubated in the presence of 2.5% CSE in comparison with cells that were incubated with medium, alone (Fig. 7) . However, c-Jun levels returned to baseline after 120 min. Experimental groups for MAP kinases included cells incubated with: medium alone; cells exposed to CSE without other activators; cells exposed to GM-CSF + TNF-α without CSE: and cells exposed to GMCSF +TNFαand CSE. ERK1/2, p38, and JNK levels were measured by flow cytometry after intracellular staining with specific antibodies. Due to technical difficulties results were obtained only for ERK phosphorylation and are shown in Fig. 8 . CSE at a concentration of 2.5% failed to induce ERK 1/2 phosphorylation in eosinophils incubated in medium, alone. Activation of eosinophils with TNF-α and GM-CSF induced a transient increase in ERK1/2 phosphorylation relative to non-stimulated controls (not shown). Adding 2.5% CSE had no influence on ERK1/2 phosphorylation. Thus, it was concluded that ERK1/2 does not appear to be involved in activation of c-Jun expression after exposure to CSE. The results of our preliminary studies, taken together with those of other studies, suggest that exposure to cigarette smoke may augment lung inflammation through its effects on eosinophils. How this might occur is summarized in the model shown in Fig. 9 . In this model, cigarette smoke has a direct effect on eosinophils by causing the release IL-8 and IL-6 and by inducing degranulation and release of other proinflammatory mediators. As a result, neutrophils are recruited into the inflamed tissue enhancing the ongoing inflammatory process. IL-6, being a strong pro inflammatory and pro-angiogenic mediator enhances the inflammatory response. TNF-α, released mainly by macrophages and lung epithelial cells after exposure to CS potentates the release of IL-8 and IL-6 by eosinophils. GM-CSF, besides being a survival factor, acts synergistically together with TNF-α to enhance CS-induced cytokine release from eosinophils. Although our study model is similar to those used in similar investigations to evaluate cigarette smoke effects on inflammatory cells [ 68 ] , it is difficult to extrapolate its results to the in vivo situation as metabolic processes that would convert cigarette smoke constituents into more-or lessharmful metabolites could not be taken into account, nor te could their concentrations. Also, experimental exposure to CSE was relatively short rm; therefore, the results cannot be extrapolated to what occurs in chronic smokers who are exposed to these chemicals over many years. Nevertheless, our study identified some important potential proinflammatory effects of cigarette smoke through its actions on eosinophils, and points to how cigarette smoke exposure might exacerbate asthma and other chronic lung inflammatory diseases.
